Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
140 Results Found
Reply in Support of Plaintiffs’ Motion to Hold Unlawful and Remedy Defendants’ Past Underpayment of 340b Drugs
The U.S. District Court for the District of Columbia should reject the Department of Health and Human Services’ request to devise on its own timeline a remedy for its 2018 and 2019 underpayments to 340B hospitals, with no limitations and no oversight by the court, AHA told the D.C. court today.
Judge Orders HHS to Immediately Halt Unlawful Reimbursement Cuts for Remainder of 2022
Judge orders HHS to immediately halt unlawful reimbursement cuts for remainder of 2022 re: 340B.
Amicus Briefs
The AHA weighs in on a number of issues of importance to hospitals and health systems, as well as the patients they care for, as they come before the court. Below are our most recent friend-of-the-court briefs.
Plaintiffs’ Opposition to Defendant’s Motion to Modify This Court’s Mandamus Order Re Medicare Appeals
AHA urges the U.S. District Court for the District of Columbia to deny the Department of Health and Human Services’ request to modify a court order requiring it to completely eliminate the remaining 19,802 Medicare appeals backlogged at the Administration Law Judge level. HHS now contends that it cannot fully comply with the order, stating that “it is unlikely that the backlog could be reduced completely to zero by the end of the fiscal year.”
AHA's Reply in Support of Plaintiffs’ Motion to Vacate the Unlawful Portion of the 2022 OPPS Rule Re: 340B
AHA files reply brief as district court considers 340B payment remedy for the remainder of 2022.
Amicus Brief: Hospital Groups Urge Appeals Court to Uphold 340B Requirements In Contract Pharmacy Case
The AHA, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, and Children’s Hospital Association yesterday filed a friend-of-the-court brief urging the U.S. Courts of Appeals for the 3rd Circuit to require drug companies to fulfill their legal obligations to provide 340B discounted drugs to eligible hospitals and health systems, regardless of whether the drugs are dispensed on site or through contract pharmacies.
Amicus Brief: AHA, Hospital Groups Urge Appeals Courts to Uphold 340B Requirements Re: Sanofi-Aventis U.S. v. HHS et al
The AHA, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, and Children’s Hospital Association yesterday urged the U.S. Courts of Appeals for the 3rd and District of Columbia Circuits to require drug companies to fulfill their legal obligations to provide 340B discounted drugs to eligible hospitals and health systems, regardless of whether the drugs are dispensed on site or through contract pharmacies.
AHA v Becerra March 2022 Medicare Appeals Dashboard
AHA v Becerra March 2022 Medicare Appeals Dashboard
AHA v Becerra March 2022 Status Report and Dashboard
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF COLUMBIA